Selenium is a trace element and an essential nutrient.
The biological importance of selenium is incompletely understood, but it is an essential part of the enzyme glutathione peroxidase,4 which protects cells from oxidative damage. Additionally, a large number of studies have now shown an inverse relation between serum selenium concentrations and the incidence of cancer.' Furthermore, selenium has been shown to have antiproliferative,912 antiinflammatory,'3 antiviral,'4 " and immune altering effects.
The pathogenesis of rheumatoid arthritis is not completely understood but, clearly, synovial proliferation and inflammation play a central part in disease expression. Therefore the antiproliferative, anti-inflammatory, and immune modulating effects of selenium are of interest. A number of studies have shown that serum selenium concentrations are lower in patients with rheumatoid arthritis than in controls. '6 17 These studies were reported from areas of relatively low selenium intakes, however. We report here the serum selenium concentrations in a large number of patients with a variety of rheumatic diseases in an area where selenium intakes are relatively high. selenium concentrations between patients with rheumatoid arthritis and osteoarthritis and controls did not seem to be due to non-steroidal anti-inflammatory drug treatment as use of these drugs was similar in all three groups. Our findings are in agreement with most other studies previously published.'6 17 Some, however, have reported normal serum selenium concentrations in patients with rheumatoid arthritis not receiving steroids,20 and others have reported normal glutathione peroxidase activity (which usually correlates well with serum selenium concentrations) in the serum of patients with rheumatoid arthritis.2' Our study differs from previous studies in that we considered larger numbers of patients and included controls with and without rheumatic disease. Additionally, our patients came from an area of relatively high selenium intake and those previously reported were from areas of low selenium intake. We found a negative correlation between selenium concentrations and activity of disease in rheumatoid patients, as has been previously reported by others.'7 Disease duration has previously been reported to have a negative correlation with selenium concentrations,'7 but we found no effect of disease duration. Additionally, we found no effect of steroid treatment on selenium concentrations, possibly because our patients were receiving low doses (5-10 mg of prednisone a day) compared with those previously reported (20-40 mg/day)20 to decrease selenium concentrations.
Although the weight of evidence suggests that a relative selenium deficiency is seen in patients with rheumatoid arthritis, it is unclear whether this deficiency has a role in the pathogenesis of rheumatoid arthritis or whether it is merely a consequence of the disease or its treatment. Several factors argue against a role for selenium in the pathogenesis of rheumatoid arthritis-for example, the prevalence of rheumatoid arthritis is similar in areas of high or low selenium intake22 24 
